Boston Aesthetics INC

Boston Aesthetics Inc. is a medical device manufacturer specializing in aesthetic and dermatological treatment systems. The company develops comfort-first, non-invasive energy-based devices for professional clinical use and home therapeutic applications. Their product portfolio includes the ZenTite fractional radiofrequency (RF) platform for professional aesthetic use, designed for skin rejuvenation and body contouring with emphasis on reduced pain and precision treatment delivery. The company also manufactures the Boston MFUS, a microfocused ultrasound system for non-invasive aesthetic applications. For home and clinical therapeutic use, Boston Aesthetics offers the Zen 308, a 308nm ultraviolet phototherapy system indicated for treatment of vitiligo, psoriasis, leukoderma, and atopic dermatitis. The company markets devices through medical aesthetics channels including med spas, dermatology clinics, and aesthetic treatment centers. Boston Aesthetics operates as the U.S. partner of Peninsula Medical Group and positions itself as an innovator in 'comfort-first' aesthetic technology, emphasizing that effective treatments do not require high pain levels. The company actively participates in major medical aesthetic and dermatological conferences including the American Academy of Dermatology (AAD), American Society for Laser Medicine and Surgery (ASLMS), Aesthetic Next, and Dubai Derma. Products are intended for professional practitioners and qualified home users seeking evidence-based aesthetic and therapeutic dermatological solutions.